Valuation : Haemonetics Corporation

Market Cap 4.73B 4.08B 3.82B 3.49B 6.57B 452B 6.59B 45.34B 17.69B 228B 17.76B 17.37B 757B P/E 2027 *
26.2x
P/E 2028 * 23.1x
Enterprise Value 5.39B 4.65B 4.36B 3.98B 7.49B 515B 7.52B 51.68B 20.17B 260B 20.24B 19.8B 863B EV / Sales 2027 *
3.81x
EV / Sales 2028 * 3.4x
Free-Float
98.74%
Yield 2027 *
0.96%
Yield 2028 * -
1 day-0.99%
1 week-4.45%
Current month+21.53%
1 month+25.95%
3 months+55.07%
6 months+64.18%
Current year+29.71%
1 week 103.57
Extreme 103.57
109.49
1 month 80.83
Extreme 80.83
109.57
Current year 51
Extreme 51
109.57
1 year 47.32
Extreme 47.315
109.57
3 years 47.32
Extreme 47.315
109.57
5 years 43.5
Extreme 43.5
109.57
10 years 32.76
Extreme 32.76
142.11
Manager TitleAgeSince
Chief Executive Officer 62 16/05/2016
Director of Finance/CFO 55 11/04/2022
Chief Operating Officer 56 01/04/2025
Director TitleAgeSince
Director/Board Member 73 01/01/2006
Director/Board Member 62 16/05/2016
Director/Board Member 71 18/10/2017
Date Insider Type Main position Quantity % Market Cap.
24/07/26 Free

Director

2,538 0.0056%
24/07/26 Free

Director

2,538 0.0056%
24/07/26 Free

Director

2,538 0.0056%
Change 5-day change 1-year change 3-year change Capi.($)
-0.99%-4.45%+91.31%+17.64% 4.73B
+0.79%-3.58%-14.39%+9.42% 195B
+1.40%-2.27%-0.79%+12.09% 117B
+0.25%+1.25%+11.09%+78.52% 61.45B
-0.25%-1.97%+26.78%+53.11% 51.03B
+0.74%-1.29%-0.90%-32.69% 51.62B
+1.71%-1.65%+20.96%-8.53% 34.27B
+1.82%+2.98% - - 30.95B
-2.49%-4.42%+37.49%-16.34% 23.75B
-0.82%-1.17%-4.66%+18.23% 23.41B
Average +0.22%-1.43%+18.54%+14.61% 59.26B
Weighted average by Cap. +0.66%-1.88%+1.85%+15.89%

Financials

2027 *2028 *
Net sales 1.41B 1.22B 1.14B 1.04B 1.97B 135B 1.97B 13.56B 5.29B 68.26B 5.31B 5.2B 226B 1.49B 1.28B 1.2B 1.1B 2.07B 142B 2.08B 14.27B 5.57B 71.84B 5.59B 5.47B 238B
Net income 177M 153M 143M 131M 247M 16.96B 247M 1.7B 664M 8.56B 666M 652M 28.38B 207M 179M 167M 153M 288M 19.81B 289M 1.99B 775M 10B 778M 761M 33.15B
Net Debt 662M 570M 535M 488M 920M 63.27B 923M 6.35B 2.48B 31.94B 2.49B 2.43B 106B 327M 282M 264M 241M 455M 31.26B 456M 3.14B 1.22B 15.78B 1.23B 1.2B 52.33B
Logo Haemonetics Corporation
Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.
Employees
3,009
Date Price Change Volume
28/08/26 $103.96 -0.99% 659,227
27/08/26 $105.00 -1.50% 592,857
26/08/26 $106.60 -1.59% 661,285
25/08/26 $108.32 -0.07% 502,183
24/08/26 $108.40 -0.37% 641,055
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
103.96USD
Average target price
106.40USD
Spread / Average Target
+2.35%

Quarterly revenue - Rate of surprise